Cytori CEO Calhoun on Stem Cell Therapies, Contract

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Sept. 28 (Bloomberg) -- Christopher Calhoun, chief executive officer of Cytori Therapeutics Inc., talks about the company's $4.7 million contract with the U.S. government to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. The contract may be worth $106 million over five years if certain milestones are met. Calhoun speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change